Univariate regression | Multivariate regression | |||
---|---|---|---|---|
Predictors of maternal complications | ||||
OR | CI 95% | aOR | CI 95% | |
Parity | 2.09 | [1.14–3.82] | 2.41 | [1.12–5.16] |
Valve disease revealed during pregnancy | 3.08 | [1.04–9.11] | 6.34 | [1.26–31.77] |
Severe Mitral stenosis | 6.98 | [2–24.32] | 6.84 | [1.14–41.05] |
PASP (mmHg) | 1.1 | [1.04–1.16] | 1.08 | [1.01–1.14] |
Predictors of obstetric complications | ||||
Nulliparity | 2.17 | [0.7–6.69] | 5.22 | [1.15–23.6] |
Multiple valve disease | 2.67 | [0.87–8.24] | 5.26 | [1.19–23.2] |
PASP (mmHg) | 1.03 | [1.001–1.076] | 1.04 | [1.002–1.09] |
Anticoagulant use | 5.67 | [1.71–18.7] | 8.71 | [1.98–38.2] |
Predictors of neonatal complications | ||||
Obstetric events | 7.2 | [2.1–23.8] | 16.47 | [3.2–84.3] |
Valve disease revealed during pregnancy | 2.6 | [0.9–7.6] | 7.33 | [1.4–36.1] |